amoxicillin and clavulanic acid | J01C R02
Film-coated tablets
amoxicillin and clavulanic acid | J01C R02
Film-coated tablets
amoxicillin and enzyme inhibitor | J01CR02
Tablets
Treatment of bacterial infections caused by susceptible to medicinal product microorganisms, such as acute bacterial sinusitis; acute otitis media; confirmed exacerbation of chronic bronchitis; community-acquired pneumonia; cystitis; pyelonephritis; infections of skin and soft tissues, including cellulitis, animal bites, severe dentoalveolar abscesses with advanced cellulite; bone and joint infections, including osteomyelitis.
ampicillin | J01C A01
Tablets
Infections caused by microorganisms susceptible to the drug: biliary tract infections (cholangitis, cholecystitis); respiratory tract infections and infections of ENT organs (pneumonia, bronchitis, pulmonary abscess, sinusitis, pharyngitis, otitis, tonsillitis); meningitis; gastroenteritis due to shigellas or salmonellas, typhoid and paratyphoid fever; bacterial endocarditis; urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis, gonorrhea); peritonitis; septicemia; skin and soft tissue infections.
ampicillin | J01C A01
Powder for injection
Infections caused by microorganisms susceptible to the drug: biliary tract infections (cholangitis, cholecystitis), respiratory tract infections (pneumonia, bronchitis, pulmonary abscess), meningitis, gastroenteritis due to salmonellas or shigellas, typhoid and paratyphoid fever, bacterial endocarditis, urinary tract infections (pyelitis, pyelonephritis, cystitis, urethritis), septicemia, skin and soft tissue infections.
аmpicillin and enzyme inhibitor | J01CR01
Powder for injection
Bacterial infections due to microorganisms susceptible to the drug: ear, larynx, nose infections (sinusitis, otitis media, epiglottitis, tonsillitis, pharyngitis); respiratory tract infections (bronchitis, pneumonia); urinary tract infections (cystitis, pyelonephritis); intraperitoneal infections (peritonitis, cholecystitis); obstetric and gynecologic infections (endometritis, parametritis, salpingo-oophoritis); sepsis; skin and soft tissue infections; infections of bones and joints (osteomyelitis, arthritis); gonococcal infections; anaerobic infections. Preoperative prophylaxis of suppurative complications in surgery, obstetrics and gynecology.
tiazotic acid morpholinium salt | АТХ С01Е В23
solution for injection
In the complex treatment of coronary heart disease: angina pectoris, myocardial infarction.
tiazotic acid | С01Е В23.
potassium, magnesium aspartate | А12СС30
Solution for injection
For additional therapy for chronic heart disease (heart failure, myocardial infarction), cardiac rhythm disturbances (primarily ventricular arrhythmias); additional therapy in the treatment of digitalis drugs.
The presented package image matches the product design registered with the Ukrainian regulatory authorities.
If you have noticed any differences, please call us at +380 44 490 75 22
If you have information about any adverse effects or other drug-related problems, please fill in the form